Download - Acute Lymphoblastic Leukemia (All)
![Page 1: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/1.jpg)
ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Definition Leukemia: Uncontrolled neoplastic
proliferation of hematopoietic cells in the bone marrow.
Acute: based on presentation i.e early onset, presents early and may die early.
First disseminated cancer shown to be curable and as such has represented the model malignancy for the principle of cancer diagnosis, prognosis and treatment.
![Page 2: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/2.jpg)
Epidemiology
It is the second most common childhood cancer in Kenya after Burkitt lymphoma
Leukaemia account for about 20% of peadiatric malignancies in Kenya with ALL being 68% of this.
It has a striking peak incidence between 2-6years of age and occurs slightly more frequently in boys than in girls.
![Page 3: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/3.jpg)
Etiology Etiology is unknown. Several genetic and environmental
factors are associated with childhood leukemia:
![Page 4: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/4.jpg)
Genetic conditions: Down syndrome Turner syndrome Fanconi syndrome Neurofibromatosis Bloom syndrome Ataxia telangiectasia Diamond blackfan anaemia Severe combined immune deficiency Schwachman syndrome Paroxysmal nocturnal hamoglobinuna Kleinfelters syndrome Li freumeni syndrome
![Page 5: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/5.jpg)
Environmental factors
Ionizing radiation Drugs Alkylating agents Nitrosourea Epipodophyllotoxin Benzene exposure Advanced maternal age
![Page 6: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/6.jpg)
Pathogenesis
The classification of ALL depends on characterizing the malignant cell in the bone marrow to determine the morphology, phenotypic characteristics as measured by cell membrane markers, and cytogenetic and molecular genetic features.
Morphology alone is usually adequate for diagnosis, the others are for disease classification and prognosis and choice appropriate therapy
![Page 7: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/7.jpg)
FAB classification L1 – Lymphoblast are predominantly small, with
little cytoplasm L2 – Larger and pleomorphic with increased
cytoplasm, irregular nuclear shape and prominent nucleoli
L3 – finely stippled and homogeneous nuclear chromatic, prominent nucleoli and deep blue cytoplasm with prominent vacuolization. Also known as Burkitt leukaemia – one of the most rapidly growing cancer in humans.
85% of ALL derived from progenitors of B celli and about 15% are derived from T cells and about 1% are derived from B cell (relatively mature)
Chromosomal abnormalities are found in most patients with ALL.
No staging system fro ALL
![Page 8: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/8.jpg)
Clinical manifestations
Initial presentation is usually non-specific and has been present for a short while (4wks)
Anorexia Fatigue Irritability Low-grade fever Patients often have a history of an
upper respiratory tract infection in the proceeding 1-2 months. Some may have a skin rash.
![Page 9: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/9.jpg)
Clinical manifestations For the few who present later, symptoms
are predominantly localised to the bones or joints, and may include joint swelling
There may also be abdominal discomfort. As the disease progresses, signs and
symptoms of bone marrow failure become obvious
Pallor and fatigue – anaemia Bruising and epistaxis –thrombocytopenia Fever – (neutropenia, malignancy) - 25%
may be due to and infection such as URTI or otitis media
![Page 10: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/10.jpg)
On examination
Pallor Purpuric and petechial skin lesions Mucous membrane hemorrhage Lymphadenopathy Splenomegaly Hepatomegaly (less common) Tenderness on bone palpation Joint swelling and effusion
![Page 11: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/11.jpg)
Rarely, sign of intracranial pressure, such as headache and vomiting, indicate leukaemic meningeal involvement - (Meningeal lymphomatosis) so have papilledema, cranial nerve palsies, seizures, nuchal rigidity.
Hyperviscosity syndrome may occur. Respiratory distress – usually related
to anaemia but may occur due to mediastinal mass of lymphoblasts. Seen typically in adolescent boys with T-cell ALL
![Page 12: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/12.jpg)
Diagnosis
1) Diagnostic testsFull blood count Hb- anemia WBC counts. May be raised, normal
or decreased. Majority of patients have a WBC count of less than 10,000/mm3
Platelets – thrombocytopenia (some pts (¼) have level >100,000/mm3
![Page 13: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/13.jpg)
Peripheral blood film Usually reported as atypical
lymphocytes. These are blasts in circulation
Bone Marrow Aspirate Leukemic lymphoblasts Occasionally BMA may be hypocellular
– do biopsy. ALL is diagnosed by bone marrow cells
being 25% lymphoblast
![Page 14: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/14.jpg)
Other diagnostic tests
Cytochemical staining To differentiate from AMLType of leukemia
PAS Sudan black/ Peroxidase
Lysozyme esterase
ALL ++ - -
AML - +++ N
![Page 15: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/15.jpg)
Cell markers (flow cytometry) To further classify into B cell, T cell or
Pre B Surface markers e.g. B cells: TdT, CD34, CD20, CD24, CD10. T cell: CD7, CD2, CD5. CD10 is also known as common ALL
antigen (CALLA) Good prognosis.Cytogenetics Chromosomal alterations e.g.
Translocations. Poor prognosis.
![Page 16: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/16.jpg)
2. Tests for disease burden and spread
Chest x-ray – check for mediastinal mass.
CSF – Lymphoblasts and CSF leukocyte count increased.
Bone radiographs – may show altered medullary trabeculae, cortical defects or subepiphyseal bone resorption
Biochemistry- LDH levels.
![Page 17: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/17.jpg)
3. Investigations for therapy or treatment.
LFTs U/E/C Septic screening
![Page 18: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/18.jpg)
Differential diagnosis
Acute myeloblastic leukemia Subcutaneous nodules or
“blueberry muffin” lesions Infiltration of the gingiva and
parotid gland (uncommon) Signs and lab findings of DIC (esp.
acute promyelocytic leukemia) Discrete masses – chloromas or
granulocytic sarcomas
![Page 19: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/19.jpg)
Other DDX Juvenile rheumatoid arthritis Rheumatic fever Infections mononucleosis Leukemoid cxn in fnfxns. Tb, Histoplasmosis,
granulomelons disease Pertussis Acute hemolytic syndrome Sickle cell disease Disease associated with BM failure.
Malignant – neuroblastoma, rhabdomyosarcona, Ewing sarcoma, retinoblatorw Non-Malignant – Aplastic anaemia
![Page 20: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/20.jpg)
Treatment
Supportive Definitive; chemotherapy and
irradiation
![Page 21: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/21.jpg)
Supportive care
Family and patient counselling. This include disease aetiology, treatment design and cost, treatment side effect (and associated complication) and prognosis
Screening and management of infections. Third generation cephalosporins singly or in combination with an aminoglycoside
Pain control. Start with NSAIDs – morphine is the ultimate (Addiction unwarranted if rx is of short period of time)
![Page 22: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/22.jpg)
Anti-emetics; Use plasil (metochlopromide), Phenergan (promethazine) dexamethasone or Motilium singly or in combination. Ondansetron or tropisetron (5HT receptor antagonists) severe emesis either singly or in combination with dexamethasome or plasil
Haematological support; With exception of vincnistine, prednisone and L-asparaginars, all other cytotoxic drugs cause myelosuppression. Total neutrophil count below 100,/mm3 Hb <9g/dI, and platelet count <20000/mm3 – product transfusion before further chemotherapy.
![Page 23: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/23.jpg)
Education rehabilitation – long duration of hospitalization
Nutritional support Management of metabolic
complication; Tumor lysis syndrome: Hypocalcaemia,Hyperuricemia (give allopunnol 10mg/kg/day (bd or TID) Maximum of 200mg TID) hyperkalemia and Hyperphosphatemia
![Page 24: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/24.jpg)
Investigations before treatment
LFTs U/E/C Septic screening
![Page 25: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/25.jpg)
Chemotherapy
Patients are divided into 1. low risks 2. high riskAccording to age, wbc count and
response to initial steroid therapy.
![Page 26: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/26.jpg)
Risk groupsLow Risk High Risk
AGE 2-10YRS <2yrs and >10yrs
WBC COUNT
< 20,000/mm³
>20000/mm³
INITIAL RESPONSE TO STEROID THERAPY
Good (< 1000 blasts/mm³)
Poor (>1000 blasts/mm³)
![Page 27: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/27.jpg)
Treatment is divided into :1. Remission induction2. Consolidation3. CNS prophylaxis4. Maintenance
![Page 28: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/28.jpg)
Induction Start prednisone tabs 60mg/m2 (as TID)
after diagnosis and give for one week than assess total blast count. Allopurinol is commenced at least 24 hours before and IT cystosar (cytosine arabinoside) or methotraxate given during diagnostic LP.
Tabs prednisone-3 weeks then tail down. IV vincristine- 4 weeks IV adriamycin- 4 weeks(Omit adnamycin
in low risk disease) IT methotrexate or cytosar weekly for 4
weeks
![Page 29: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/29.jpg)
If CNS disease is present, alternate IT methotrexate and cytostar weekly for total of 10 doses then monthly IT adding hydrocortisone for 6 months
![Page 30: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/30.jpg)
Consolidation (Two courses 7-10 days apart)
IV cyclophosphamide -single dose IV cytosar- once daily for 4 days 6 mercaptopunne- once daily for 4
weeks Bone marrows aspirate to assess
remission status before commencement of maintenance therapy. If not in remission, repeat a third course of consolidation
![Page 31: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/31.jpg)
Cranial irradiation
![Page 32: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/32.jpg)
Maintenance
Monthly (2yrs) Vincristine 6 mercaptopurine Methotrexate Prednisone Doses of 6mp or MTX may be
adjusted upward or downwards to maintain leucocytes counts between 1500-3500
![Page 33: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/33.jpg)
Maintenance
3 monthly (1 year) Adnamycin Cyclophosphomide
![Page 34: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/34.jpg)
Relapse
Usually those with T cell type. The bone marrow is the most
common site of relapse, although almost any site can be affected.
Extramedullary sites, - Most common CNS and testes.
Treatment of testes- Testicular irradiation. chemo should be reinforced for patients who are still undergoing rx or reinstituted for those who have a relapse after treatment
![Page 35: Acute Lymphoblastic Leukemia (All)](https://reader036.vdocuments.us/reader036/viewer/2022081420/55cf8586550346484b8ef77e/html5/thumbnails/35.jpg)
Prognosis
Treatment is the single most important prognostics factor. The earlier the better.
Other than these are Age <2 - >10yrs, Initial leucocyte count - >20,000/mm³ poor prognosis.
CALLA good prognosis. Philadelphia chromosomes – poor
prognosis. And other translocatins- poor prognosis